Literature DB >> 22447972

Concomitant activation of functionally opposing prostacyclin and thromboxane prostanoid receptors by cyclo-oxygenase-1-mediated prostacyclin synthesis in mouse arteries.

Bin Liu1, Wenhong Luo, Yingzhan Zhang, Hui Li, Jiling Zhang, Xue-Rui Tan, Yingbi Zhou.   

Abstract

This study aimed to determine whether cyclo-oxygenase-1 (COX-1) mediates dilatation of mouse arteries via synthesis of prostacyclin (PGI(2)) and, if so, how PGI(2) (IP) receptors contribute and whether thromboxane prostanoid (TP) receptors are implicated in the process. Mesenteric arteries were isolated from wild-type mice or mice with COX-1 deficiency (COX-1(-/-)). The vasomotor reaction to the COX substrate arachidonic acid (AA) was determined with isometric force measurement, while the in vitro production or the plasma level of the PGI(2) metabolite 6-keto-PGF(1α) was analysed with high-performance liquid chromatography-mass spectroscopy or enzyme immunoassay, respectively. Results showed that AA, which evoked endothelium-dependent 6-keto-PGF(1α) production, elicited relaxation that was inhibited or enhanced by antagonizing IP or TP receptors, respectively. Also, IP receptor blockade resulted in contraction in response to AA (following NO synthase inhibition), which was prevented by a concomitant TP receptor antagonism. Meanwhile, COX-1(-/-) or COX-1 inhibition abolished the in vitro 6-keto-PGF(1α) production and reduced the relaxation or contraction observed with AA. Real-time PCR showed that whereas TP receptor mRNAs were detected at similar levels, IP receptor mRNAs were present at higher levels in the branches than in the main stem of the mesenteric artery. In addition, antagonizing the IP receptors enhanced the contraction evoked by PGI(2) in the carotid artery. Also, we noted that COX-1(-/-) mice had a reduced basal plasma 6-keto-PGF(1α) level. These results demonstrate an explicit vasodilator role for COX-1-mediated endothelial PGI(2) synthesis and suggest that the functionally opposing IP and TP receptors concomitantly mediate the vasomotor reaction to PGI(2), with the dilator activity of IP receptors being compromised by the vasoconstrictor effect of TP receptors and vice versa.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22447972     DOI: 10.1113/expphysiol.2011.063784

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  10 in total

1.  Aspirin-triggered 15-epi-lipoxin A4 predicts cyclooxygenase-2 in the lungs of LPS-treated mice but not in the circulation: implications for a clinical test.

Authors:  Nicholas S Kirkby; Melissa V Chan; Martina H Lundberg; Karen A Massey; William M B Edmands; Louise S MacKenzie; Elaine Holmes; Anna Nicolaou; Timothy D Warner; Jane A Mitchell
Journal:  FASEB J       Date:  2013-06-21       Impact factor: 5.191

2.  Role of E-type prostaglandin receptor EP3 in the vasoconstrictor activity evoked by prostacyclin in thromboxane-prostanoid receptor deficient mice.

Authors:  Zhenhua Li; Yingzhan Zhang; Bin Liu; Wenhong Luo; Hui Li; Yingbi Zhou
Journal:  Sci Rep       Date:  2017-02-06       Impact factor: 4.379

3.  Increased role of E prostanoid receptor-3 in prostacyclin-evoked contractile activity of spontaneously hypertensive rat mesenteric resistance arteries.

Authors:  Bin Liu; Mengyi Zhan; Yingzhan Zhang; Hui Li; Xiangzhong Wu; Fengfeng Zhuang; Wenhong Luo; Yingbi Zhou
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

4.  EP3 Blockade Adds to the Effect of TP Deficiency in Alleviating Endothelial Dysfunction in Atherosclerotic Mouse Aortas.

Authors:  Chuangjia Hu; Bin Liu; Yineng Xu; Xiangzhong Wu; Tingting Guo; Yingzhan Zhang; Jing Leng; Jiahui Ge; Gang Yu; Jinwei Guo; Yingbi Zhou
Journal:  Front Physiol       Date:  2019-09-26       Impact factor: 4.566

5.  Mechanistic definition of the cardiovascular mPGES-1/COX-2/ADMA axis.

Authors:  Nicholas S Kirkby; Joan Raouf; Blerina Ahmetaj-Shala; Bin Liu; Sarah I Mazi; Matthew L Edin; Mark Geoffrey Chambers; Marina Korotkova; Xiaomeng Wang; Walter Wahli; Darryl C Zeldin; Rolf Nüsing; Yingbi Zhou; Per-Johan Jakobsson; Jane A Mitchell
Journal:  Cardiovasc Res       Date:  2020-10-01       Impact factor: 10.787

6.  Endothelial cyclooxygenase-1 paradoxically drives local vasoconstriction and atherogenesis despite underpinning prostacyclin generation.

Authors:  Jane A Mitchell; Fisnik Shala; Maria Elisa Lopes Pires; Rachel Y Loy; Andrew Ravendren; Joshua Benson; Paula Urquhart; Anna Nicolaou; Harvey R Herschman; Nicholas S Kirkby
Journal:  Sci Adv       Date:  2021-03-19       Impact factor: 14.136

7.  Sexual dimorphism in prostacyclin-mimetic responses within rat mesenteric arteries: A novel role for KV 7.1 in shaping IP receptor-mediated relaxation.

Authors:  Samuel N Baldwin; Elizabeth A Forrester; Lauren McEwan; Iain A Greenwood
Journal:  Br J Pharmacol       Date:  2022-01-21       Impact factor: 9.473

8.  Vasomotor Reaction to Cyclooxygenase-1-Mediated Prostacyclin Synthesis in Carotid Arteries from Two-Kidney-One-Clip Hypertensive Mice.

Authors:  Bin Liu; Zhenhua Li; Yingzhan Zhang; Wenhong Luo; Jiling Zhang; Hui Li; Yingbi Zhou
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

9.  Arachidonic Acid Metabolite 19(S)-HETE Induces Vasorelaxation and Platelet Inhibition by Activating Prostacyclin (IP) Receptor.

Authors:  Sorin Tunaru; Ramesh Chennupati; Rolf M Nüsing; Stefan Offermanns
Journal:  PLoS One       Date:  2016-09-23       Impact factor: 3.240

Review 10.  Prostaglandins in the pathogenesis of kidney diseases.

Authors:  Yuanyuan Li; Weiwei Xia; Fei Zhao; Zhaoying Wen; Aihua Zhang; Songming Huang; Zhanjun Jia; Yue Zhang
Journal:  Oncotarget       Date:  2018-05-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.